Bumepamine, a Brain-Permeant Benzylamine Derivative of Bumetanide, Does Not Inhibit NKCC1 but Is More Potent to Enhance Phenobarbital’s Anti-Seizure Efficacy

Neuropharmacology - United Kingdom
doi 10.1016/j.neuropharm.2018.09.025

Related search